These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31230802)

  • 1. "Smart" polymer enhances the efficacy of topical antimicrobial agents.
    De Silva CC; Israni N; Zanwar A; Jagtap A; Leophairatana P; Koberstein JT; Modak SM
    Burns; 2019 Sep; 45(6):1418-1429. PubMed ID: 31230802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Topical Antimicrobial Agents Against Bacterial Isolates From Burn Wounds.
    Nethery W; Warner P; Durkee P; Dwyer A; Zembrodt J; Fowler L
    J Burn Care Res; 2020 Jul; 41(4):739-742. PubMed ID: 32303755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagenase ointment and polymyxin B sulfate/bacitracin spray versus silver sulfadiazine cream in partial-thickness burns: a pilot study.
    Soroff HS; Sasvary DH
    J Burn Care Rehabil; 1994; 15(1):13-7. PubMed ID: 8150836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wound healing. The effects of topical antimicrobial agents.
    Geronemus RG; Mertz PM; Eaglstein WH
    Arch Dermatol; 1979 Nov; 115(11):1311-4. PubMed ID: 507884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-kill Kinetics of a Novel Antimicrobial Silver Wound Gel Against Select Wound Pathogens.
    Lee Y; Atchley DH; Proctor CA; Smith FL; Yi S; Loftis CM; Yates KM
    Wounds; 2015 Dec; 27(12):336-46. PubMed ID: 27447106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for evaluating topical antimicrobial efficacy against methicillin-resistant Staphylococcus aureus biofilms in superficial murine wounds.
    Roche ED; Renick PJ; Tetens SP; Carson DL
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4508-10. PubMed ID: 22644024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent in vitro release of silver sulfadiazine and bupivacaine from semi-interpenetrating networks for wound management.
    Kleinbeck KR; Bader RA; Kao WJ
    J Burn Care Res; 2009; 30(1):98-104. PubMed ID: 19060724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silver sulfadiazine nanosuspension-loaded thermosensitive hydrogel as a topical antibacterial agent.
    Liu X; Gan H; Hu C; Sun W; Zhu X; Meng Z; Gu R; Wu Z; Dou G
    Int J Nanomedicine; 2019; 14():289-300. PubMed ID: 30643407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined topical use of silver sulfadiazine and antibiotics as a possible solution to bacterial resistance in burn wounds.
    Modak SM; Sampath L; Fox CL
    J Burn Care Rehabil; 1988; 9(4):359-63. PubMed ID: 3146573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Povidone iodine plus neosporin in superficial burns--a continuing study.
    Sinha R; Agarwal RK; Agarwal M
    Burns; 1997; 23(7-8):626-8. PubMed ID: 9568337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility testing of topical antimicrobial agents used in pediatric burn patients: comparison of two methods.
    Rodgers GL; Mortensen JE; Fisher MC; Long SS
    J Burn Care Rehabil; 1997; 18(5):406-10. PubMed ID: 9313120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo comparison of two silver sulfadiazine antimicrobial agents on burn wound infection.
    Velanovich V; Heggers JP; Robson MC; Zoellner SM; McHugh TP; Boertman J; Niu XT; Schileru R
    J Burn Care Rehabil; 1987; 8(5):381-3. PubMed ID: 3667664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wound healing in partial-thickness burn wounds treated with collagenase ointment versus silver sulfadiazine cream.
    Hansbrough JF; Achauer B; Dawson J; Himel H; Luterman A; Slater H; Levenson S; Salzberg CA; Hansbrough WB; Doré C
    J Burn Care Rehabil; 1995; 16(3 Pt 1):241-7. PubMed ID: 7673302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dealing with biofilms of Pseudomonas aeruginosa and Staphylococcus aureus: In vitro evaluation of a novel aerosol formulation of silver sulfadiazine.
    Moyano AJ; Mas CR; Colque CA; Smania AM
    Burns; 2020 Feb; 46(1):128-135. PubMed ID: 31420266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis.
    Snelling CF; Ronald AR; Waters WR; Yaworski DS; Drulak K; Sunderland M
    Can Med Assoc J; 1978 Sep; 119(5):466-70. PubMed ID: 99223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing.
    Robb EC; Nathan P
    J Trauma; 1981 Oct; 21(10):889-93. PubMed ID: 7277534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery.
    Mi FL; Wu YB; Shyu SS; Schoung JY; Huang YB; Tsai YH; Hao JY
    J Biomed Mater Res; 2002 Mar; 59(3):438-49. PubMed ID: 11774301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadexomer iodine provides superior efficacy against bacterial wound biofilms in vitro and in vivo.
    Fitzgerald DJ; Renick PJ; Forrest EC; Tetens SP; Earnest DN; McMillan J; Kiedaisch BM; Shi L; Roche ED
    Wound Repair Regen; 2017 Jan; 25(1):13-24. PubMed ID: 27859922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional Antimicrobial Nanofiber Dressings Containing ε-Polylysine for the Eradication of Bacterial Bioburden and Promotion of Wound Healing in Critically Colonized Wounds.
    Mayandi V; Wen Choong AC; Dhand C; Lim FP; Aung TT; Sriram H; Dwivedi N; Periayah MH; Sridhar S; Fazil MHUT; Goh ETL; Orive G; W Beuerman R; Barkham TMS; Loh XJ; Liang ZX; Barathi VA; Ramakrishna S; Chong SJ; Verma NK; Lakshminarayanan R
    ACS Appl Mater Interfaces; 2020 Apr; 12(14):15989-16005. PubMed ID: 32172559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical efficacy of silver sulfadiazine (AgSD: Geben cream) for ulcerative skin lesions infected with MRSA].
    Yoshida T; Ohura T; Sugihara T; Yoshida T; Ishikawa T; Homma K; Kouraba S; Kimura C; Murazumi M
    Jpn J Antibiot; 1997 Jan; 50(1):39-44. PubMed ID: 9059912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.